SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-003886
Filing Date
2020-01-08
Accepted
2020-01-08 17:10:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d851345d424b5.htm 424B5 375987
2 GRAPHIC g851345g06a25.jpg GRAPHIC 45409
3 GRAPHIC g851345g32u56.jpg GRAPHIC 44872
4 GRAPHIC g851345g85f37_268.jpg GRAPHIC 44219
  Complete submission text file 0001193125-20-003886.txt   562720
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-227209 | Film No.: 20516352
SIC: 2834 Pharmaceutical Preparations